Sort   by:  
 Page size 
UnknownA single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation.
Not available
S-EPMC5382040 | biostudies-literature
UnknownImmunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.
Not available
S-EPMC4394264 | biostudies-literature
UnknownThe regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.
Not available
S-EPMC5387133 | biostudies-literature
UnknownEarly Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia.
Not available
S-EPMC8166407 | biostudies-literature
UnknownReduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).
Not available
S-EPMC4552311 | biostudies-literature
UnknownEtiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.
Not available
S-EPMC4520535 | biostudies-literature
UnknownPhase 2 study of ibrutinib in classic and variant hairy cell leukemia.
Not available
S-EPMC8225920 | biostudies-literature
UnknownBTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.
Not available
S-EPMC5455463 | biostudies-literature
UnknownHairy cell leukemia and COVID-19 adaptation of treatment guidelines.
Not available
S-EPMC8093591 | biostudies-literature
Sort   by:  
 Page size